Shantharam Harish's most recent trade in Alx Oncology Holdings Inc was a trade of 198,750 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Harish Shantharam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2025 | 198,750 | 198,750 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Harish Shantharam | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 18 Aug 2025 | 75,000 | 75,000 | - | 0.8 | 58,403 | Common Stock |
| Alx Oncology Holdings Inc | Harish Shantharam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Harish Shantharam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Harish Shantharam | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 360,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Harish Shantharam | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 74,750 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Harish Shantharam | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 20,125 | 0 (0%) | 0% | - | Common Stock | |
| Cymabay Therapeutics Inc | Shantharam Harish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 74,750 | 74,750 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Harish Shantharam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 20,125 | 20,125 (0%) | 0% | 0 | Common Stock | |
| Cymabay Therapeutics Inc | Harish Shantharam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 360,000 | 360,000 | - | - | Employee Stock Option (right to buy) |